Smart Drugs and Cognitive Enhancers Drive Global Nootropics Market Growth

Comments ยท 24 Views

To overcome such challenges, nootropics firms must diversify their supplier networks and consider alternative sourcing locations that are politically more stable.

The Nootropics Market has witnessed significant growth over the recent past owing to the growing popularity and adoption of smart drugs. Nootropics, commonly referred to as smart drugs, are medications, supplements, or other substances that are claimed to enhance memory, concentration, and other cognitive abilities. The key types of nootropics available in the market include racetams, ampakines, choline & cholinergics, and antioxidants. Piracetam, aniripiprazole, and vinpocetine are some of the commonly consumed nootropic substances.

The Global Nootropics Market is estimated to be valued at USD 3.66 Bn in 2024. The market is expected to reach USD 8.98 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 13.7% from 2024 to 2031.


The Nootopics Market Trend is witnessing significant growth in demand from individuals seeking to enhance cognitive functions such as memory, creativity, motivation, and focus. Furthermore, the growing geriatric population prone to age-related cognitive decline has also boosted the adoption of nootropic supplements. The market is also expanding globally with companies increasingly investing in developing regions such as Asia Pacific and Middle East & Africa due to the large potential consumer base.

 

Get More Insights On-Nootropics Market

disclaimer
Comments